Pharmaceutical Industry Today

Global Aprotinin Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Aprotinin Market report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency.
Published 20 June 2018

This report studies the Aprotinin market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.

Request Sample Copy of the Report @

Currently, there are many sales companies in the world Aprotinin industry, especially in India and China. The main market players are Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited and Guangdong Techpool Bio-pharma. The sale Revenue of Aprotinin is about 123458 K USD in 2015.

North America is the largest consumption region of Aprotinin, with a Revenue market share nearly 20.28% in 2015.

The second consumption place is Europe; following North America with the Revenue market share of 19.66%. China is another important market of Aprotinin, enjoying 17.23% Revenue market share.

Aprotinin is used in Pharmaceuticals and Scientific Research & Experiment areas. Report data showed that 74.04% of the Aprotinin market demand in Pharmaceuticals and 25.96% in Scientific Research & Experiment areas in 2015.

There are three kinds of Aprotinin, which are Aprotinin (From bovine lung) and Recombinant Aprotinin. Aprotinin (From bovine lung) is wildly used in the Aprotinin, with a revenue market share nearly 81.11% in 2015.

Briefly speaking, in the next few years, Aprotinin industry will still be a highly energetic industry. Sales of Aprotinin have brought a lot of opportunities, there will more companies enter into this industry, especially in developing countries.

The global Aprotinin market was 140 million US$ in 2017 and is expected to 200 million US$ by the end of 2025, growing at a CAGR of 4.6% between 2018 and 2025.

Ask for Discount on Research Report@

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Aprotinin in these regions, from 2013 to 2025, covering

  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
  •     Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
  •     South America (Brazil etc.)
  •     Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

  •     Sigma-Aldrich
  •     BeiJing Geyuantianrun Bio-tech
  •     Cayman Chemical
  •     Taj Pharmaceuticals Limited
  •     Guangdong Techpool Bio-pharma
  •     Dadeli
  •     A.S.Joshi&Company
  •     Enzymeking Biotechnology
  •     AdooQ BioScience
  •     ProSpec
  •     Yaxin Biotechnology
  •     AMRESCO
  •     PanReac AppliChem
  •     Runhao
By the product type, the market is primarily split into
  •     Aprotinin (From bovine lung)
  •     Recombinant Aprotinin

By the end users/application, this report covers the following segments

  •     Pharmaceuticals
  •     Scientific Research & Experiment

Click to view the full report TOC, figure and tables:

Other Industry News

Ready to start publishing

Sign Up today!